Jerome Canady, MD, CEO, Chief Science Officer
Jerome Canady MD received his BA in German from Villanova University, (Villanova, PA) and his Doctorate of Medicine from Temple University School of Medicine (Philadelphia, PA). Dr. Canady completed his general surgery residency from the University of Pittsburgh, McKeesport, PA. Prior to starting his fellowships Dr. Canady was a staff surgeon at Georgetown University Hospital, Washington, D.C. Dr. Canady completed a Postdoctoral fellowship in Organ Transplantation and Immunology and a Clinical Fellowship in Organ Transplantation at Yale University School of Medicine/Yale New Haven Hospital. He completed advanced multi-organ clinical transplantation fellowships (Adult and Pediatric) at the University of Pittsburgh Medical Center, Thomas E Starzl Transplantation Institute and Children’s Hospital of Pittsburgh, Pittsburg, PA and the Humboldt Universitaet of Berlin, Virkow Klinikum, Berlin, Germany. He is a diplomate of the American Board of Surgery and certified by the American Society of Transplantation Surgeons. His field of research includes: Cold Atmospheric Plasma (CAP) in the eradication of cancer and systemic diseases and advancement of hybrid plasma technologies in surgery, endoscopy, and robotic assisted devices.
Warren Rowe III, PhD, Postdoctoral Research Scientist
Dr. Rowe received a B.Sc. in Cellular & Molecular Biology and Genetics with a minor in Astronomy from the University of Maryland, College Park, MD and completed his PhD in Microbiology and Immunology at the Virginia Commonwealth University, Richmond, VA. Dr. Rowe is currently investigating the molecular pathways and receptor expression associated with cold atmospheric plasma in cancer biology.
Xiaoqian Cheng, PhD, Senior Research Scientist
Dr. Cheng received a B.Sc. in Power Engineering of Aircraft from Nanjing University of Aeronautics and Astronautics (NUAA), China in 2011, and received her PhD in Mechanical and Aerospace Engineering from The George Washington University, focusing on Plasma Science. Currently Dr. Cheng is working on the biomedical application of cold atmospheric plasma for cancer therapy. Her current projects include Canady Helios Cold Plasma Scalpel testing and the application of cold plasma for breast cancer treatment.
Michael Keidar, Ph.D., The George Washington University, Washington DC
Barry Trink, Ph.D., Rambam Medical Center, Haifa, Israel
Alexey Shashurin, Ph.D., Purdue University, West Lafayette, IN
Giacomo Basadonna, M.D., Ph.D., University of Massachusetts School of Medicine, Worcester, MA